| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/12/2001 | EP1131340A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
| 09/12/2001 | EP1131317A1 Method for preparing (2s)-1- (2r,3s)-5- chloro-3-(2- chlorophenyl) -1-(3,4-dimethoxy benzenesulphonyl) -3-hydroxy-2, 3-dihydro-1h- indole-2-carbonyl] pyrrolidine-2- carboxamide |
| 09/12/2001 | EP1131082A2 A method for treating tissue damaged from ischemia |
| 09/12/2001 | EP1049481A4 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 09/12/2001 | EP1047445A4 Modified enzymes and their use for peptide synthesis |
| 09/12/2001 | EP0929572A4 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 09/12/2001 | EP0808326B1 Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 09/12/2001 | EP0789585B1 A storage stable water solution for infusion containing a thrombin inhibitor |
| 09/12/2001 | EP0586474B1 Peptide nucleic acids |
| 09/12/2001 | CN1312818A Chemical synthesis of exochelins |
| 09/12/2001 | CN1312817A Dolastatin 15 derivatives |
| 09/12/2001 | CN1312805A Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 09/11/2001 | US6288231 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 09/11/2001 | US6288077 2,3-methano-amino acid compounds |
| 09/11/2001 | US6288072 Anticarcinogenic and antitumor agents; leukemia |
| 09/11/2001 | US6288038 Accelerate apolipoprotein e production; nervous system disorders, alzheimer*s disease; antilipemic agents |
| 09/11/2001 | US6288037 C-terminally modified pentapeptides containing valine and aspartic acid |
| 09/11/2001 | US6287840 Peptidomimetics; coupling, deblocking; antiarthritic, antitumor, anticarcinogenic, and antimetastasis agents; muscular dystrophy, glomerulonephritis, malaria, alzheimer*s disease |
| 09/11/2001 | US6287806 Method for producing a biologically active recombinant cysteine-free peptide |
| 09/11/2001 | US6287794 Peptide having antithrombotic effect through reversible inhibition of blood coagulation factor; antiinflammatory agents; treatment of cardiovascular disorders |
| 09/11/2001 | US6287761 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 09/11/2001 | CA2125175C New peptide derivatives |
| 09/07/2001 | WO2001064738A2 Heparin-binding amino acid sequences derived from human proteins facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | WO2001055329A8 Nucleic acids, proteins, and antibodies |
| 09/07/2001 | WO2001016135A3 Reverse-turn mimetics and methods relating thereto |
| 09/07/2001 | WO2001014395A3 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 09/07/2001 | WO2000071571A3 Fap-activated anti-tumor compounds |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/06/2001 | US20010020006 Dipeptidyl peptidase; antidiabetic agents |
| 09/05/2001 | EP1129112A2 Peptides containing a cholesterol recognition sequence and their uses |
| 09/05/2001 | EP1129108A1 Caspases and apoptosis |
| 09/05/2001 | EP1129107A1 Method for producing l-prolyl-l-m-sarcolysyl-l-p-fluorophenylalanine and derivatives thereof |
| 09/05/2001 | EP0956029A4 Cyclic peptides having broad spectrum antimicrobial activity |
| 09/05/2001 | CN1311793A Antipicornaviral compounds, their prepn. and use |
| 09/04/2001 | US6284777 Carbohydrazide protease inhibitors |
| 09/04/2001 | US6284454 Variant of LAV viruses |
| 09/04/2001 | CA2224062C Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001010457A3 Pharmaceutical compositions containing tripeptides |
| 08/30/2001 | US20010018423 Anticoagulant agents |
| 08/30/2001 | US20010018422 Anticancer agents |
| 08/29/2001 | EP1127884A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them |
| 08/29/2001 | EP1127119A1 Compounds and methods for modulating claudin-mediated functions |
| 08/29/2001 | EP1127071A1 Compounds with growth hormone releasing properties |
| 08/29/2001 | CN1310626A Hybrid polypeptides with enhanced pharmacokinetic properties |
| 08/28/2001 | US6281380 From aspartyl-phenylalanine methyl ester |
| 08/28/2001 | US6281376 Therapeutic compound—fatty acid conjugates |
| 08/28/2001 | US6281352 Antiinflammatory agents |
| 08/28/2001 | US6281247 Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide |
| 08/28/2001 | US6281194 E.g., (s)-(1-((4-benzyloxy-benzyl)-(((1-phenyl-cyclobutylmethyl)-car bamoyl)-methyl)-carbamoyl)-2-(1h-imidazol-4-yl)-ethyl)-carbami c acid benzyl ester |
| 08/28/2001 | US6280760 Peptide-coated implants and methods for producing same |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/25/2001 | CA2337923A1 Peptide antibiotics |
| 08/23/2001 | WO2001061017A2 Modified cytokines for use in cancer therapy |
| 08/23/2001 | WO2001060848A2 Conjugates targeted to target receptors |
| 08/23/2001 | WO2001060843A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme |
| 08/23/2001 | WO2001060842A2 PROCESS FOR MAKING GRANULATED N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER |
| 08/23/2001 | WO2001060813A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | WO2001060416A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 08/23/2001 | US20010016570 Bone disorders |
| 08/23/2001 | DE10005932A1 Peptide und Verfahren zur Diagnostik von Zöliakie und Dermatitis Peptides and methods for the diagnosis of celiac disease and dermatitis |
| 08/23/2001 | CA2400631A1 Beta-alanine derivatives and their use as receptor antagonists |
| 08/23/2001 | CA2400627A1 Trh-like peptide derivatives as inhibitors of the trh-degrading ectoenzyme |
| 08/23/2001 | CA2398395A1 Conjugates targeted to target receptors |
| 08/23/2001 | CA2395038A1 Matrix metalloproteinase inhibitors |
| 08/22/2001 | CN1309566A Nocathiacin antibiotics |
| 08/21/2001 | US6278000 Growth-hormone secretagogues |
| 08/21/2001 | US6277863 Anticoagulant with reduced side effects |
| 08/21/2001 | US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 08/16/2001 | WO2001058957A2 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2001 | WO2001058932A1 Cytostatic agent glycoconjugate |
| 08/16/2001 | WO2001058928A1 N-terminal d(-)-penicillamine peptides as aldehyde sequestration agents |
| 08/16/2001 | WO2001058868A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058471A2 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 08/16/2001 | WO2001010893A3 Il-16 antagonists |
| 08/16/2001 | WO2001010891A3 Il-16 antagonists |
| 08/16/2001 | WO2001009173A3 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 08/16/2001 | WO2001007033A3 Neuroprotective pharmaceutical reparations comprising p-fluoroselegiline |
| 08/16/2001 | EP1123410A1 The enzyme-mediated synthesis of peptidomimetics |
| 08/16/2001 | EP1123309A2 Cyclic tetrapeptides and their use as histone deacetylase inhibitor |
| 08/16/2001 | EP1123308A1 Single morphic forms of known peptide metalloproteinase inhibitors |
| 08/16/2001 | EP1123272A1 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases |
| 08/16/2001 | EP1011668A4 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives |
| 08/16/2001 | EP0839153B1 Process of preparation of peptides and n-carbamoyl protected peptides |
| 08/16/2001 | EP0837877B1 L-aspartyl-l-thienylalanine methyl esters, process for producing them and their use as sweeteners |
| 08/16/2001 | EP0805817B1 Thiol derivatives with metallopeptidase inhibitory activity |
| 08/15/2001 | CN1308078A Camptothecin derivative and its preparation |
| 08/14/2001 | US6274705 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/09/2001 | WO2001056591A1 vMIP-II PEPTIDE ANTAGONISTS OF CXCR4 |
| 08/09/2001 | WO2001056560A1 Substituted amino acids as neutral sphingomyelinase inhibitors |
| 08/09/2001 | DE10005275A1 Neuartige Glycokonjugate Novel glycoconjugates |
| 08/09/2001 | CA2399792A1 Substituted amino acids as neutral sphingomyelinase inhibitors |
| 08/09/2001 | CA2369056A1 Vmip-ii peptide antagonists of cxcr4 |
| 08/08/2001 | EP1122262A1 Neovascular-specific peptides |
| 08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |